| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Bettina Meiser | Q60641709 |
| Tatiane Yanes | Q56522498 | ||
| P2093 | author name string | Paul A James | |
| Mary-Anne Young | |||
| P2860 | cites work | The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control study | Q27644636 |
| Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland | Q28140600 | ||
| Large-scale genotyping identifies 41 new loci associated with breast cancer risk | Q29416989 | ||
| Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial. | Q30238753 | ||
| Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease | Q30665466 | ||
| Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers | Q33614244 | ||
| Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model | Q33763777 | ||
| Breast cancer risk assessment using genetic variants and risk factors in a Singapore Chinese population | Q33892384 | ||
| Performance of common genetic variants in breast-cancer risk models | Q34064069 | ||
| Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information | Q34267477 | ||
| Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25. | Q34375940 | ||
| Genome-wide association studies: theoretical and practical concerns | Q34555195 | ||
| A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2. | Q35082982 | ||
| Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance | Q35777905 | ||
| Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer | Q35996692 | ||
| The contributions of breast density and common genetic variation to breast cancer risk | Q36137764 | ||
| SNPs and breast cancer risk prediction for African American and Hispanic women | Q36322904 | ||
| Polygenic Determinants for Subsequent Breast Cancer Risk in Survivors of Childhood Cancer: The St Jude Lifetime Cohort Study (SJLIFE) | Q58113261 | ||
| Differential Burden of Rare and Common Variants on Tumor Characteristics, Survival, and Mode of Detection in Breast Cancer | Q58546894 | ||
| Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas | Q61448654 | ||
| Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes | Q62583133 | ||
| Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants | Q64004339 | ||
| High-risk women's risk perception after receiving personalized polygenic breast cancer risk information. | Q64934338 | ||
| A role for common genomic variants in the assessment of familial breast cancer | Q85312916 | ||
| Transmission of breast cancer polygenic risk based on single nucleotide polymorphisms | Q89195707 | ||
| BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors | Q91045517 | ||
| Polygenic Risk Scores That Predict Common Diseases Using Millions of Single Nucleotide Polymorphisms: Is More, Better? | Q91942122 | ||
| A response to "Personalised medicine and population health: breast and ovarian cancer" | Q91960210 | ||
| Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification | Q92638472 | ||
| Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-BRCA1/2 breast cancer families | Q92666340 | ||
| A polygenic risk score for breast cancer in U.S. Latinas and Latin-American women | Q95729658 | ||
| Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement | Q36393193 | ||
| Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
| Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry | Q36619329 | ||
| Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families | Q37131918 | ||
| Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status | Q37223335 | ||
| Genetic counseling as a tool for type 2 diabetes prevention: a genetic counseling framework for common polygenetic disorders | Q37312886 | ||
| Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab | Q37410693 | ||
| Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry | Q37487782 | ||
| The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers | Q37578078 | ||
| Incorporating genomics into breast and prostate cancer screening: assessing the implications | Q37614763 | ||
| Assessing women at high risk of breast cancer: a review of risk assessment models | Q37739036 | ||
| Genetic modifiers of CHEK2*1100delC-associated breast cancer risk | Q37739048 | ||
| Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes | Q38613552 | ||
| Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study | Q38776757 | ||
| A polygenic risk score for breast cancer risk in a Taiwanese population. | Q38958555 | ||
| Clinical implications of genomics for cancer risk genetics | Q38996690 | ||
| Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones. | Q40089754 | ||
| Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium | Q40282176 | ||
| Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer | Q40346126 | ||
| Breast cancer risk prediction using a clinical risk model and polygenic risk score | Q40605693 | ||
| Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and Metastasis | Q41080132 | ||
| The WISDOM Study: breaking the deadlock in the breast cancer screening debate | Q41701590 | ||
| Association analysis identifies 65 new breast cancer risk loci. | Q45979098 | ||
| Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting | Q46060663 | ||
| Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer | Q46103372 | ||
| Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium | Q47190168 | ||
| Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry | Q47207156 | ||
| Making Sense of SNPs: Women's Understanding and Experiences of Receiving a Personalized Profile of Their Breast Cancer Risks. | Q47822347 | ||
| 'A low risk is still a risk': exploring women's attitudes towards genetic testing for breast cancer susceptibility in order to target disease prevention | Q48233913 | ||
| Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials. | Q48717652 | ||
| Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction. | Q49964811 | ||
| Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs. | Q50050350 | ||
| Evaluation of three polygenic risk score models for the prediction of breast cancer risk in Singapore Chinese. | Q55040393 | ||
| Validation of a genetic risk score for Arkansas women of color | Q57040851 | ||
| Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model | Q57177092 | ||
| Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers | Q57339170 | ||
| Personalised medicine and population health: breast and ovarian cancer | Q57453316 | ||
| BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts | Q57466036 | ||
| Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study | Q57748350 | ||
| Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations | Q57910661 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 21 | |
| P577 | publication date | 2020-02-17 | |
| P1433 | published in | Breast Cancer Research | Q2208481 |
| P1476 | title | Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field | |
| P478 | volume | 22 |
| Q104073603 | Integrative genomic analysis implicates ERCC6 and its interaction with ERCC8 in susceptibility to breast cancer | cites work | P2860 |
Search more.